Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen + magnesium + vitamin C for acute pain in temporomandibular disorder
2014-003790-41Phase 2Active
- Sponsor
- Spherium Biomed
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ibuprofen, Magnesium aspartate and ascorbic acid in temporomandibular disorder (TMD) (3 arms), sponsored by Spherium Biomed. Primary endpoint: Change in pain severity at 7 days. Started Feb 2015; status: active.
02
Drugs
ibuprofenMagnesium aspartateascorbic acid
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on 2014-003790-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003790-41.